This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-101-3p | SOX9 | -1.48 | 0 | 0.46 | 0.17811 | miRNAWalker2 validate; miRNATAP | -0.92 | 0 | 23178713 | Ectopic expression of miR-101 significantly inhibited HCC cell proliferation and tumorigenicity by targeting SOX9; Therefore miR-101 may suppress HCC tumor progression by down-regulating SOX9 |
2 | hsa-miR-30e-5p | SOX9 | -0.63 | 0 | 0.46 | 0.17811 | MirTarget | -0.79 | 0 | NA | |
3 | hsa-miR-616-5p | SOX9 | 0.15 | 0.40284 | 0.46 | 0.17811 | mirMAP; miRNATAP | -0.34 | 0.0002 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 21 | 1008 | 1.734e-13 | 8.067e-10 |
2 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 23 | 1381 | 9.078e-13 | 2.112e-09 |
3 | CELLULAR RESPONSE TO HORMONE STIMULUS | 16 | 552 | 1.861e-12 | 2.886e-09 |
4 | RESPONSE TO ENDOGENOUS STIMULUS | 23 | 1450 | 2.493e-12 | 2.9e-09 |
5 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 25 | 1848 | 6.312e-12 | 5.874e-09 |
6 | RESPONSE TO HORMONE | 18 | 893 | 2.515e-11 | 1.95e-08 |
7 | RESPONSE TO LIPID | 17 | 888 | 2.279e-10 | 1.515e-07 |
8 | RESPONSE TO NITROGEN COMPOUND | 16 | 859 | 1.294e-09 | 7.525e-07 |
9 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 15 | 799 | 4.259e-09 | 2.202e-06 |
10 | CELLULAR RESPONSE TO LIPID | 12 | 457 | 4.89e-09 | 2.276e-06 |
11 | REGULATION OF HORMONE LEVELS | 12 | 478 | 8.073e-09 | 3.415e-06 |
12 | POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 5 | 36 | 5.537e-08 | 2.147e-05 |
13 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 11 | 465 | 6.712e-08 | 2.342e-05 |
14 | REGULATION OF CELL DEATH | 18 | 1472 | 7.048e-08 | 2.342e-05 |
15 | LIPID METABOLIC PROCESS | 16 | 1158 | 8.748e-08 | 2.714e-05 |
16 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 12 | 602 | 1.018e-07 | 2.959e-05 |
17 | RESPONSE TO PEPTIDE | 10 | 404 | 1.875e-07 | 4.846e-05 |
18 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 8 | 218 | 1.83e-07 | 4.846e-05 |
19 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 14 | 917 | 2.004e-07 | 4.907e-05 |
20 | RESPONSE TO ACID CHEMICAL | 9 | 319 | 2.741e-07 | 6.378e-05 |
21 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 18 | 1618 | 2.926e-07 | 6.482e-05 |
22 | STEROID METABOLIC PROCESS | 8 | 237 | 3.462e-07 | 7.321e-05 |
23 | REPRODUCTION | 16 | 1297 | 4.093e-07 | 7.963e-05 |
24 | HORMONE METABOLIC PROCESS | 7 | 164 | 4.107e-07 | 7.963e-05 |
25 | CELLULAR HORMONE METABOLIC PROCESS | 6 | 104 | 5.003e-07 | 9.311e-05 |
26 | SEX DIFFERENTIATION | 8 | 266 | 8.289e-07 | 0.0001483 |
27 | RESPONSE TO LITHIUM ION | 4 | 27 | 9.906e-07 | 0.0001707 |
28 | OXIDATION REDUCTION PROCESS | 13 | 898 | 1.079e-06 | 0.0001793 |
29 | RESPONSE TO STEROID HORMONE | 10 | 497 | 1.243e-06 | 0.0001994 |
30 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 18 | 1805 | 1.459e-06 | 0.0002189 |
31 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 10 | 505 | 1.435e-06 | 0.0002189 |
32 | ANDROGEN METABOLIC PROCESS | 4 | 30 | 1.537e-06 | 0.0002235 |
33 | GLAND DEVELOPMENT | 9 | 395 | 1.625e-06 | 0.0002291 |
34 | RESPONSE TO INSULIN | 7 | 205 | 1.838e-06 | 0.0002515 |
35 | REPRODUCTIVE SYSTEM DEVELOPMENT | 9 | 408 | 2.12e-06 | 0.000274 |
36 | ORGANIC ACID METABOLIC PROCESS | 13 | 953 | 2.091e-06 | 0.000274 |
37 | POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 75 | 2.33e-06 | 0.000293 |
38 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 7 | 216 | 2.6e-06 | 0.0003184 |
39 | CELLULAR RESPONSE TO INSULIN STIMULUS | 6 | 146 | 3.646e-06 | 0.000435 |
40 | TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER | 6 | 153 | 4.778e-06 | 0.0005515 |
41 | REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 5 | 87 | 4.859e-06 | 0.0005515 |
42 | HORMONE MEDIATED SIGNALING PATHWAY | 6 | 158 | 5.75e-06 | 0.0006337 |
43 | SYSTEM PROCESS | 17 | 1785 | 5.857e-06 | 0.0006337 |
44 | CELL DEVELOPMENT | 15 | 1426 | 7.377e-06 | 0.0007802 |
45 | ANDROGEN BIOSYNTHETIC PROCESS | 3 | 14 | 7.813e-06 | 0.0008079 |
46 | MULTICELLULAR ORGANISM REPRODUCTION | 11 | 768 | 9.15e-06 | 0.0009255 |
47 | REGULATION OF GLUCOSE TRANSPORT | 5 | 100 | 9.626e-06 | 0.0009331 |
48 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 7 | 263 | 9.471e-06 | 0.0009331 |
49 | CELLULAR RESPONSE TO PEPTIDE | 7 | 274 | 1.236e-05 | 0.001173 |
50 | REGULATION OF GLUCOSE METABOLIC PROCESS | 5 | 106 | 1.279e-05 | 0.00119 |
51 | REGULATION OF CELL PROLIFERATION | 15 | 1496 | 1.313e-05 | 0.001198 |
52 | CELLULAR RESPONSE TO LITHIUM ION | 3 | 17 | 1.451e-05 | 0.001274 |
53 | POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 3 | 17 | 1.451e-05 | 0.001274 |
54 | RESPONSE TO AMINO ACID | 5 | 112 | 1.671e-05 | 0.00144 |
55 | NOTCH SIGNALING PATHWAY | 5 | 114 | 1.821e-05 | 0.001541 |
56 | LIPID BIOSYNTHETIC PROCESS | 9 | 539 | 1.995e-05 | 0.001657 |
57 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 12 | 1004 | 2.089e-05 | 0.001705 |
58 | DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 202 | 2.329e-05 | 0.001869 |
59 | REGULATION OF GLUCOSE IMPORT | 4 | 60 | 2.567e-05 | 0.00199 |
60 | RESPONSE TO ABIOTIC STIMULUS | 12 | 1024 | 2.538e-05 | 0.00199 |
61 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 12 | 1036 | 2.847e-05 | 0.002045 |
62 | RESPONSE TO OXYGEN LEVELS | 7 | 311 | 2.791e-05 | 0.002045 |
63 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 12 | 1036 | 2.847e-05 | 0.002045 |
64 | RESPONSE TO DRUG | 8 | 431 | 2.857e-05 | 0.002045 |
65 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 5 | 125 | 2.841e-05 | 0.002045 |
66 | NEGATIVE REGULATION OF CELL DEATH | 11 | 872 | 2.98e-05 | 0.002101 |
67 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 5 | 128 | 3.184e-05 | 0.002211 |
68 | RESPONSE TO IMMOBILIZATION STRESS | 3 | 22 | 3.252e-05 | 0.002226 |
69 | REGULATION OF REPRODUCTIVE PROCESS | 5 | 129 | 3.305e-05 | 0.002229 |
70 | RESPONSE TO EXTRACELLULAR STIMULUS | 8 | 441 | 3.363e-05 | 0.002235 |
71 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 15 | 1672 | 4.852e-05 | 0.003179 |
72 | POSITIVE REGULATION OF CELL DEATH | 9 | 605 | 4.919e-05 | 0.003179 |
73 | RESPONSE TO INORGANIC SUBSTANCE | 8 | 479 | 6.024e-05 | 0.00384 |
74 | EPITHELIUM DEVELOPMENT | 11 | 945 | 6.19e-05 | 0.003892 |
75 | MUSCLE HYPERTROPHY | 3 | 28 | 6.835e-05 | 0.004191 |
76 | TISSUE DEVELOPMENT | 14 | 1518 | 6.845e-05 | 0.004191 |
77 | HOMEOSTATIC PROCESS | 13 | 1337 | 7.713e-05 | 0.004661 |
78 | NEGATIVE REGULATION OF CELL PROLIFERATION | 9 | 643 | 7.858e-05 | 0.004688 |
79 | REGULATION OF NEURON DEATH | 6 | 252 | 7.99e-05 | 0.004706 |
80 | MONOCARBOXYLIC ACID METABOLIC PROCESS | 8 | 503 | 8.474e-05 | 0.004868 |
81 | BROWN FAT CELL DIFFERENTIATION | 3 | 30 | 8.437e-05 | 0.004868 |
82 | SMALL MOLECULE METABOLIC PROCESS | 15 | 1767 | 9.133e-05 | 0.005182 |
83 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 15 | 1784 | 0.0001018 | 0.005706 |
84 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 5 | 168 | 0.0001159 | 0.006421 |
85 | REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 4 | 89 | 0.0001209 | 0.006616 |
86 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 172 | 0.0001294 | 0.007003 |
87 | REGULATION OF GLYCOGEN METABOLIC PROCESS | 3 | 35 | 0.0001346 | 0.007201 |
88 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 3 | 36 | 0.0001466 | 0.007646 |
89 | REGULATION OF LIPID METABOLIC PROCESS | 6 | 282 | 0.0001479 | 0.007646 |
90 | REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 3 | 36 | 0.0001466 | 0.007646 |
91 | REGULATION OF GLUCONEOGENESIS | 3 | 38 | 0.0001725 | 0.00882 |
92 | DRUG METABOLIC PROCESS | 3 | 39 | 0.0001865 | 0.009418 |
93 | MULTI ORGANISM REPRODUCTIVE PROCESS | 10 | 891 | 0.0001882 | 0.009418 |
94 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 9 | 724 | 0.0001926 | 0.009534 |
95 | DICARBOXYLIC ACID METABOLIC PROCESS | 4 | 101 | 0.0001971 | 0.009652 |
96 | RHYTHMIC PROCESS | 6 | 298 | 0.0001994 | 0.009667 |
97 | UROGENITAL SYSTEM DEVELOPMENT | 6 | 299 | 0.0002031 | 0.009742 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | OXYGEN BINDING | 5 | 47 | 2.2e-07 | 0.0002044 |
2 | STEROID HORMONE RECEPTOR ACTIVITY | 5 | 59 | 6.996e-07 | 0.0002166 |
3 | OXIDOREDUCTASE ACTIVITY | 12 | 719 | 6.808e-07 | 0.0002166 |
4 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 11 | 629 | 1.351e-06 | 0.0002511 |
5 | DOUBLE STRANDED DNA BINDING | 12 | 764 | 1.289e-06 | 0.0002511 |
6 | STEROID HYDROXYLASE ACTIVITY | 4 | 31 | 1.761e-06 | 0.0002727 |
7 | REGULATORY REGION NUCLEIC ACID BINDING | 12 | 818 | 2.621e-06 | 0.00034 |
8 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 8 | 315 | 2.928e-06 | 0.00034 |
9 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 7 | 226 | 3.507e-06 | 0.000362 |
10 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 8 | 328 | 3.947e-06 | 0.0003666 |
11 | STEROID BINDING | 5 | 91 | 6.063e-06 | 0.0004694 |
12 | MACROMOLECULAR COMPLEX BINDING | 15 | 1399 | 5.85e-06 | 0.0004694 |
13 | INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 3 | 15 | 9.747e-06 | 0.0006965 |
14 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 4 | 48 | 1.051e-05 | 0.0006971 |
15 | TRANSCRIPTION FACTOR BINDING | 9 | 524 | 1.596e-05 | 0.0009883 |
16 | ENZYME BINDING | 16 | 1737 | 1.819e-05 | 0.001056 |
17 | HORMONE BINDING | 4 | 65 | 3.526e-05 | 0.001927 |
18 | TETRAPYRROLE BINDING | 5 | 134 | 3.966e-05 | 0.002047 |
19 | PROTEIN COMPLEX BINDING | 11 | 935 | 5.624e-05 | 0.00275 |
20 | IRON ION BINDING | 5 | 163 | 0.0001006 | 0.004671 |
21 | SEQUENCE SPECIFIC DNA BINDING | 11 | 1037 | 0.0001416 | 0.006263 |
22 | MONOOXYGENASE ACTIVITY | 4 | 95 | 0.0001556 | 0.006571 |
23 | PROTEIN HOMODIMERIZATION ACTIVITY | 9 | 722 | 0.0001887 | 0.007621 |
24 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 4 | 104 | 0.0002205 | 0.008536 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04510_Focal_adhesion | 7 | 200 | 1.559e-06 | 0.0002759 | |
2 | hsa00140_Steroid_hormone_biosynthesis | 4 | 57 | 2.092e-05 | 0.001852 | |
3 | hsa04910_Insulin_signaling_pathway | 5 | 138 | 4.565e-05 | 0.002693 | |
4 | hsa04512_ECM.receptor_interaction | 4 | 85 | 0.0001011 | 0.004473 | |
5 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 3 | 42 | 0.0002328 | 0.008243 | |
6 | hsa00830_Retinol_metabolism | 3 | 64 | 0.0008084 | 0.02064 | |
7 | hsa04920_Adipocytokine_signaling_pathway | 3 | 68 | 0.0009645 | 0.02064 | |
8 | hsa04115_p53_signaling_pathway | 3 | 69 | 0.001006 | 0.02064 | |
9 | hsa03320_PPAR_signaling_pathway | 3 | 70 | 0.001049 | 0.02064 | |
10 | hsa00020_Citrate_cycle_.TCA_cycle. | 2 | 30 | 0.003298 | 0.05838 | |
11 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 3 | 136 | 0.006885 | 0.1108 | |
12 | hsa04150_mTOR_signaling_pathway | 2 | 52 | 0.009658 | 0.1414 | |
13 | hsa00500_Starch_and_sucrose_metabolism | 2 | 54 | 0.01039 | 0.1414 | |
14 | hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 | 2 | 71 | 0.01749 | 0.2101 | |
15 | hsa04662_B_cell_receptor_signaling_pathway | 2 | 75 | 0.01939 | 0.2101 | |
16 | hsa04370_VEGF_signaling_pathway | 2 | 76 | 0.01988 | 0.2101 | |
17 | hsa04070_Phosphatidylinositol_signaling_system | 2 | 78 | 0.02087 | 0.2101 | |
18 | hsa04664_Fc_epsilon_RI_signaling_pathway | 2 | 79 | 0.02137 | 0.2101 | |
19 | hsa04810_Regulation_of_actin_cytoskeleton | 3 | 214 | 0.02315 | 0.2146 | |
20 | hsa04012_ErbB_signaling_pathway | 2 | 87 | 0.02558 | 0.2146 | |
21 | hsa04914_Progesterone.mediated_oocyte_maturation | 2 | 87 | 0.02558 | 0.2146 | |
22 | hsa04210_Apoptosis | 2 | 89 | 0.02668 | 0.2146 | |
23 | hsa04010_MAPK_signaling_pathway | 3 | 268 | 0.04098 | 0.3093 | |
24 | hsa04114_Oocyte_meiosis | 2 | 114 | 0.04195 | 0.3093 | |
25 | hsa04722_Neurotrophin_signaling_pathway | 2 | 127 | 0.0509 | 0.3263 | |
26 | hsa04110_Cell_cycle | 2 | 128 | 0.05162 | 0.3263 | |
27 | hsa00190_Oxidative_phosphorylation | 2 | 132 | 0.05452 | 0.3328 | |
28 | hsa04310_Wnt_signaling_pathway | 2 | 151 | 0.06903 | 0.3941 |